1
|
Choo QL, Kuo G, Weiner AJ, Overby LR,
Bradley DW and Houghton M: Isolation of a cDNA clone derived from a
blood-borne non-A, non-B viral hepatitis genome. Science.
244:359–362. 1989. View Article : Google Scholar
|
2
|
Giannini C and Bréchot C: Hepatitis C
virus biology. Cell Death Differ. 10(Suppl 1): S27–S38. 2003.
View Article : Google Scholar
|
3
|
Simmonds P, Holmes EC, Cha TA, Chan SW,
McOmish F, Irvine B, Beall E, Yap PL, Kolberg J and Urdea MS:
Classification of hepatitis C virus into six major genotypes and a
series of subtypes by phylogenetic analysis of NS-5 region. J Gen
Virol. 74:2391–2399. 1993. View Article : Google Scholar : PubMed/NCBI
|
4
|
Simmonds P, Bukh J, Combet C, et al:
Consensus proposals for a unified system of nomenclature of
hepatitis C virus genotypes. Hepatology. 42:962–973. 2005.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Büchen-Osmond C: ICTVdB - The Universal
Virus Database Version 4. Colombia University; New York, NY:
2004
|
6
|
Reed KE and Rice CM: Overview of hepatitis
C virus genome structure, polyprotein processing, and protein
properties. Current Topics in Microbiology and Immunology: The
Hepatitis C Viruses. Hagedorn CH and Rice CM: Springer; Heidelberg:
pp. 55–84. 2000, PubMed/NCBI
|
7
|
Walewski JL, Keller TR, Stump DD and
Branch AD: Evidence for a new hepatitis C virus antigen encoded in
an overlapping reading frame. RNA. 7:710–721. 2001. View Article : Google Scholar : PubMed/NCBI
|
8
|
Xu Z, Choi J, Yen TS, et al: Synthesis of
a novel hepatitis C virus protein by ribosomal frameshift. EMBO J.
20:3840–3848. 2001. View Article : Google Scholar : PubMed/NCBI
|
9
|
Boulant S, Becchi M, Penin F and Lavergne
JP: Unusual multiple recoding events leading to alternative forms
of hepatitis C virus core protein from genotype 1b. J Biol Chem.
278:45785–45792. 2003. View Article : Google Scholar : PubMed/NCBI
|
10
|
Branch AD, Stump DD, Gutierrez JA, Eng F
and Walewski JL: The hepatitis C virus alternate reading frame
(ARF) and its family of novel products: the alternate reading frame
protein/F-protein, the double-frameshift protein, and others. Semin
Liver Dis. 25:105–117. 2005. View Article : Google Scholar
|
11
|
Vassilaki N and Mavromara P: The HCV
ARFP/F/core+1 protein: production and functional analysis of an
unconventional viral product. IUBMB Life. 61:739–752. 2009.
|
12
|
Marusawa H, Hijikata M, Chiba T and
Shimotohno K: Hepatitis C virus core protein inhibits Fas-and tumor
necrosis factor alpha-mediated apoptosis via NF-kappaB activation.
J Virol. 73:4713–4720. 1999.PubMed/NCBI
|
13
|
Ray RB, Meyer K and Ray R: Suppression of
apoptotic cell death by hepatitis C virus core protein. Virology.
226:176–182. 1996. View Article : Google Scholar : PubMed/NCBI
|
14
|
Vassilaki N, Friebe P, Meuleman P, et al:
Role of the hepatitis C virus core+1 open reading frame and core
cis-acting RNA elements in viral RNA translation and replication. J
Virol. 82:11503–11515. 2008.
|
15
|
Basu A, Steele R, Ray R and Ray RB:
Functional properties of a 16 kDa protein translated from an
alternative open reading frame of the core-encoding genomic region
of hepatitis C virus. J Gen Virol. 85:2299–2306. 2004. View Article : Google Scholar : PubMed/NCBI
|
16
|
Ray RB, Steele R, Meyer K and Ray R:
Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter
activity. Gene. 208:331–336. 1998. View Article : Google Scholar : PubMed/NCBI
|
17
|
Kong J, Deng X, Wang Z, Yang J, Zhang Y
and Yu J: Hepatitis C virus F protein: A double-edged sword in the
potential contribution of chronic inflammation to carcinogenesis.
Mol Med Rep. 2:461–469. 2009.PubMed/NCBI
|
18
|
Brooks DG, Trifilo MJ, Edelmann KH, Teyton
L, McGavern DB and Oldstone MB: Interleukin-10 determines viral
clearance or persistence in vivo. Nat Med. 12:1301–1309. 2006.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Di Bisceglie AM and Hoofnagle JH: Optimal
therapy of hepatitis C. Hepatology. 36(5 Suppl 1): S121–S127.
2002.PubMed/NCBI
|
20
|
Anthony DD, Yonkers NL, Post AB, et al:
Selective impairments in dendritic cell-associated function
distinguish hepatitis C virus and HIV infection. J Immunol.
172:4907–4916. 2004. View Article : Google Scholar : PubMed/NCBI
|
21
|
Goutagny N, Vieux C, Decullier E, et al:
Quantification and functional analysis of plasmacytoid dendritic
cells in patients with chronic hepatitis C virus infection. J
Infect Dis. 189:1646–1655. 2004. View
Article : Google Scholar : PubMed/NCBI
|
22
|
Dolganiuc A, Chang S, Kodys K, et al:
Hepatitis C virus (HCV) core protein-induced, monocyte-mediated
mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell
loss in chronic HCV infection. J Immunol. 177:6758–6768. 2006.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Yue M, Deng X, Zhai X, et al: Th1 and Th2
cytokine profiles induced by hepatitis C virus F protein in
peripheral blood mononuclear cells from chronic hepatitis C
patients. Immunol Lett. 152:89–95. 2013. View Article : Google Scholar : PubMed/NCBI
|
24
|
Kalamvoki M, Georgopoulou U and Mavromara
P: The NS5A protein of the hepatitis C virus genotype 1a is cleaved
by caspases to produce C-terminal-truncated forms of the protein
that reside mainly in the cytosol. J Biol Chem. 281:13449–13462.
2006. View Article : Google Scholar : PubMed/NCBI
|
25
|
Amjad M, Abdel-Haq N, Faisal M, Kamal M
and Moudgal V: Decreased interferon-alpha production and impaired
regulatory function of plasmacytoid dendritic cells induced by the
hepatitis C virus NS 5 protein. Microbiol Immunol. 52:499–507.
2008. View Article : Google Scholar
|
26
|
Krug A, Rothenfusser S, Hornung V, et al:
Identification of CpG oligonucleotide sequences with high induction
of IFN-alpha/beta in plasmacytoid dendritic cells. Eur J Immunol.
31:2154–2163. 2001. View Article : Google Scholar : PubMed/NCBI
|
27
|
Landmann R, Knopf HP, Link S, Sansano S,
Schumann R and Zimmerli W: Human monocyte CD14 is upregulated by
lipopolysaccharide. Infect Immun. 64:1762–1769. 1996.PubMed/NCBI
|
28
|
Shao SW, Wu WB, Bian ZQ, et al: Hepatitis
C virus F protein inhibits cell apoptosis by activation of
intracellular NF-kappa-B pathway. Hepatol Res. 39:282–289. 2009.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Komurian-Pradel F, Rajoharison A, Berland
JL, et al: Antigenic relevance of F protein in chronic hepatitis C
virus infection. Hepatology. 40:900–909. 2004. View Article : Google Scholar : PubMed/NCBI
|
30
|
Colonna M, Trinchieri G and Liu YJ:
Plasmacytoid dendritic cells in immunity. Nat Immunol. 5:1219–1226.
2004. View
Article : Google Scholar
|
31
|
Shoukry NH, Cawthon AG and Walker CM:
Cell-mediated immunity and the outcome of hepatitis C virus
infection. Annu Rev Microbiol. 58:391–424. 2004. View Article : Google Scholar : PubMed/NCBI
|
32
|
Barrett L, Gallant M, Howley C, et al:
Enhanced IL-10 production in response to hepatitis C virus proteins
by peripheral blood mononuclear cells from human immunodeficiency
virus-monoinfected individuals. BMC Immunol. 9:282008. View Article : Google Scholar
|
33
|
Siavoshian S, Abraham JD, Thumann C, Kieny
MP and Schuster C: Hepatitis C virus core, NS3, NS5A, NS5B proteins
induce apoptosis in mature dendritic cells. J Med Virol.
75:402–411. 2005. View Article : Google Scholar : PubMed/NCBI
|
34
|
De Vries JE and Malefyt RDW:
Interleukin-10. RG Landes Co; Austin, TX: 1995
|
35
|
Martin-Blondel G, Gales A, Bernad J, et
al: Low interleukin-10 production by monocytes of patients with a
self-limiting hepatitis C virus infection. J Viral Hepat.
16:485–491. 2009. View Article : Google Scholar : PubMed/NCBI
|
36
|
Palucka K and Banchereau J: Dendritic
cells: a link between innate and adaptive immunity. J Clin Immunol.
19:12–25. 1999. View Article : Google Scholar : PubMed/NCBI
|
37
|
Banchereau J, Briere F, Caux C, et al:
Immunobiology of dendritic cells. Annu Rev Immunol. 18:767–811.
2000. View Article : Google Scholar
|
38
|
Pulendran B, Banchereau J, Maraskovsky E
and Maliszewski C: Modulating the immune response with dendritic
cells and their growth factors. Trends Immunol. 22:41–47. 2001.
View Article : Google Scholar : PubMed/NCBI
|
39
|
Lozach PY, Lortat-Jacob H, de Lacroix de
Lavalette A, et al: DC-SIGN and L-SIGN are high affinity binding
receptors for hepatitis C virus glycoprotein E2. J Biol Chem.
278:20358–20366. 2003. View Article : Google Scholar : PubMed/NCBI
|
40
|
Geijtenbeek TB, Torensma R, van Vliet SJ,
et al: Identification of DC-SIGN, a novel dendritic cell-specific
ICAM-3 receptor that supports primary immune responses. Cell.
100:575–585. 2000. View Article : Google Scholar : PubMed/NCBI
|